• Company
• Generic companies lastly challenge Lixiana patent
• by Kim, Jin-Gu Sep 4, 2024 05:48am

• Policy
• Alvogen voluntarily recalls Comtan Tab due to impurities
• by Lee, Hye-Kyung Sep 3, 2024 05:53am

• Company
• Pharma companies jump into developing 'TPD' for cancer
• by Son, Hyung-Min Sep 3, 2024 05:53am

• Policy
• Prolia’s drug price cut 30% before the entry of biosimilars
• by Lee, Tak-Sun Sep 3, 2024 05:53am

• Policy
• Rival party heads discuss pending issue in NA
• by Lee, Jeong-Hwan Sep 3, 2024 05:53am

• Policy
• Usage recommendations for 3 JAK inhibitors to be changed
• by Lee, Tak-Sun Sep 3, 2024 05:53am

• Policy
• Pfizer's new COVID-19 vaccine wins nod in KOR
• by Lee, Hye-Kyung Sep 2, 2024 05:48am

• Company
• Biological drug options for psoriasis treatment increase
• by Son, Hyung-Min Sep 2, 2024 05:48am

• Company
• Yuhan’s Leclaza targets US mkt based on its clinical effect
• by Hwang, Byung-woo Sep 2, 2024 05:48am

• Company
• Tevimbra may be prescribed in general hospitals in KOR
• by Eo, Yun-Ho Sep 2, 2024 05:48am